ストックスクリーナーアプリを入手
0.6675
41.03%
-0.5025
前日終値:
$1.17
開ける：
$0.68
24時間の取引高:
16,875
Relative Volume:
66.00
時価総額：
$N/A
収益：
-
当期純損益:
$-16.63M
株価収益率:
-1.5523
EPS:
-0.43
ネットキャッシュフロー:
$-21.84M
1週間 パフォーマンス:
-41.03%
1か月 パフォーマンス:
-43.90%
6か月 パフォーマンス:
-68.49%
1年 パフォーマンス:
-87.10%
1日の値動き範囲:
$0.65
$0.69
1週間の範囲:
$0.65
$0.69
52週間の値動き範囲:
$0.65
$0.69
Brainstorm Cell Therapeutics Inc Stock (BCLI) Company Profile
BCLI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCLI
Brainstorm Cell Therapeutics Inc
|
0.6675 | 0 | 0 | -16.63M | -21.84M | -0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-02-04 | アップグレード | Maxim Group | Hold → Buy |
| 2020-11-17 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-12-19 | 繰り返されました | Maxim Group | Buy |
| 2015-12-22 | 繰り返されました | Maxim Group | Buy |
Brainstorm Cell Therapeutics Inc (BCLI) 最新ニュース
What momentum indicators show for Brainstorm Cell Therapeutics Inc. stockJuly 2025 Rallies & Long Hold Capital Preservation Plans - newser.com
Why analysts recommend Brainstorm Cell Therapeutics Inc. (GHD) stockJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
Why Brainstorm Cell Therapeutics Inc. stock remains on watchlistsJuly 2025 WrapUp & AI Enhanced Trading Signals - newser.com
Can Brainstorm Cell Therapeutics Inc. stock hit record highs again2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Long term hold vs stop loss in Brainstorm Cell Therapeutics Inc.Market Rally & Scalable Portfolio Growth Methods - newser.com
Understanding Brainstorm Cell Therapeutics Inc.’s price movementTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Analyzing Brainstorm Cell Therapeutics Inc. with risk reward ratio chartsJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Can a trend reversal in Brainstorm Cell Therapeutics Inc. lead to recoveryEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
Real time social sentiment graph for Brainstorm Cell Therapeutics Inc.July 2025 Movers & AI Based Buy and Sell Signals - newser.com
What institutional flow reveals about Brainstorm Cell Therapeutics Inc.Dividend Hike & AI Forecast for Swing Trade Picks - newser.com
Best data tools to analyze Brainstorm Cell Therapeutics Inc. stockCEO Change & Weekly Momentum Picks - newser.com
Strategies to average down on Brainstorm Cell Therapeutics Inc.July 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
Is Brainstorm Cell Therapeutics Inc. stock overvalued by current metricsQuarterly Trade Report & Daily Growth Stock Tips - newser.com
Published on: 2025-11-03 00:06:56 - newser.com
Is Brainstorm Cell Therapeutics Inc. (GHD) stock ideal for retirement investorsWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Brainstorm Cell Therapeutics Inc. stock outlook for YEARJuly 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com
Should I buy Brainstorm Cell Therapeutics Inc. (GHD) stock before earnings seasonMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
Published on: 2025-10-31 03:39:48 - newser.com
Published on: 2025-10-30 06:39:18 - newser.com
Applying chart zones and confluence areas to Brainstorm Cell Therapeutics Inc.M&A Rumor & Fast Exit Strategy with Risk Control - newser.com
Published on: 2025-10-30 01:07:34 - newser.com
What MACD trends signal for Brainstorm Cell Therapeutics Inc. (GHD) stockWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - newser.com
Brainstorm Cell Therapeutics (BCLI) Price Target Decreased by 13.95% to 17.34 - Nasdaq
Brainstorm Cell Therapeutics Inc (BCLI) 財務データ
収益
当期純利益
現金流量
EPS
1.45%
0.86%
大文字化:
|
ボリューム (24 時間):